Filing Details
- Accession Number:
- 0001203311-16-000078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-23 19:44:08
- Reporting Period:
- 2016-03-21
- Filing Date:
- 2016-03-23
- Accepted Time:
- 2016-03-23 19:44:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-21 | 4,282 | $4.45 | 560,397 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-21 | 4,282 | $35.01 | 556,115 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-03-22 | 10,954 | $4.45 | 567,069 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-22 | 10,054 | $35.69 | 557,015 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-22 | 900 | $36.14 | 556,115 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-03-21 | 4,282 | $0.00 | 4,282 | $4.45 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-03-22 | 10,954 | $0.00 | 10,954 | $4.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 56,655 | 2016-09-05 | No | 4 | M | Direct | |
| 45,701 | 2016-09-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 27,945 | Indirect | by Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- Sale price represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 to this Form 4.
- Sale price represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Shares vested at a rate of 25% on 9/06/07 and monthly thereafter until all the shares were fully vested on 9/06/10.
Billionaire Hedge Funds
